focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Instruments Regulatory News (OXIG)

Share Price Information for Oxford Instruments (OXIG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,405.00
Bid: 2,210.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 195.00 (8.824%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 2,405.00
OXIG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

16 Apr 2024 07:00

RNS Number : 7048K
Oxford Instruments PLC
16 April 2024
 

 

Oxford Instruments plc

Trading Update - 16 April 2024

 

 

Full year trading in line with expectations

Positive momentum in revenue growth

 

Oxford Instruments plc, a leading global provider of scientific technology and expertise to academic and commercial partners, is today issuing a trading update for the year ended 31 March 2024.

 

Revenue growth for the year has been strong and is expected to be up around 9% at constant currency (6% at actual rates) on the prior year. Our differentiated positions are driving positive momentum, with growth across all our geographies in our key sustainability-driven and structurally growing end markets, including advanced materials, life science and semiconductors. While orders were lower against a strong comparator year and due to a slowdown in life science OEM orders, our underlying book-to-bill remains positive.

 

Operating margin is expected to be approximately 100bps behind last year, reflecting losses incurred in our quantum business as a result of ceasing commercial activities in China, and continued operational investment.

 

We expect adjusted operating profit for the full year ended 31 March 2024 to be in line with expectations.1

 

The Group enters the new financial year with a strong order book providing good visibility to planned revenues and a good pipeline of growth opportunities in structurally growing end markets.

 

Oxford Instruments' results for the year ending 31 March 2024 will be released on 11 June 2024, together with an update on the Group's strategy.

 

On 10 July 2024, we will host an investor and analyst site visit at our new etch and deposition systems facility in Bristol, which is now operational. The focus will be on the products and services we provide within the compound semiconductor industry.

 

 

 

Notes:

 

1 Adjusted operating profit is before amortisation and impairment of acquired intangible assets, acquisition items, and the mark-to-market revaluation of financial derivatives.

 

 

 

Enquiries:

 

Oxford Instruments plc

Richard Tyson, CEO

Gavin Hill, CFO

Stephen Lamacraft, Head of Investor Relations

Tel: 01865 393200

 

 

MHP

Katie Hunt/Tim Rowntree/Eleni Menikou/Veronica Farah

oxfordinstruments@mhpc.com

Tel: 020 3128 8100

 

 

 

 

- Ends -

 

Issued for and on behalf of Oxford Instruments plc

 

Notes to Editors  

 

About Oxford Instruments plc

Oxford Instruments designs, supplies andsupports high-technology products and systems which allow the world's leading companies and scientific research communities to image, analyse and manipulate materials down to the atomic and molecular level. The Group's products and services help its customers to accelerate R&D, increase manufacturing productivity and make ground-breaking discoveries across its key market segments: Semiconductor & Communications, Advanced Materials, Healthcare & Life Science, Energy & Environment and Quantum Technology.

Innovation is the driving force behind Oxford Instruments' growth and success, supporting its core purpose to enable a greener, healthier, more connected advanced society. Founded in 1959 as the first technology business to be spun out fromOxfordUniversity, Oxford Instruments is now a global company listed on the FTSE250 index of the London Stock Exchange (OXIG). Its customer-centric, market-focused strategy creates competitive advantage through understanding the technical and commercial challenges in markets with long-term structural growth drivers.

 

For more information, visit www.oxinst.com 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTQKPBBFBKDKQD
Date   Source Headline
8th Jun 20217:00 amRNSPreliminary Results
3rd Jun 202112:49 pmPRNTotal Voting Rights
11th May 20212:13 pmPRNDirector/PDMR Shareholding
22nd Apr 20219:50 amPRNDirector/PDMR Shareholding
6th Apr 20213:43 pmPRNHolding(s) in Company
26th Mar 20217:00 amRNSTrading Update
11th Mar 20215:05 pmPRNDirector/PDMR Shareholding
10th Mar 20219:12 amPRNHolding(s) in Company
4th Mar 20214:48 pmPRNHolding(s) in Company
11th Feb 20214:24 pmPRNHolding(s) in Company
11th Feb 20211:26 pmPRNDirector/PDMR Shareholding
4th Feb 20214:42 pmPRNHolding(s) in Company
27th Jan 20218:00 amPRNDirectorate Change
12th Jan 202110:56 amPRNDirector/PDMR Shareholding
7th Jan 20214:09 pmPRNTotal Voting Rights
7th Jan 20213:29 pmPRNBlocklisting - Interim Review
11th Dec 202011:27 amPRNDirector/PDMR Shareholding
3rd Dec 20201:22 pmPRNTotal Voting Rights
27th Nov 20204:42 pmRNSSecond Price Monitoring Extn
27th Nov 20204:37 pmRNSPrice Monitoring Extension
17th Nov 202010:51 amPRNDirector/PDMR Shareholding-2nd amendment
17th Nov 202010:35 amPRNDirector/PDMR Shareholding - amendment
17th Nov 20208:58 amPRNDirector/PDMR Shareholding
12th Nov 20203:04 pmPRNDirector/PDMR Shareholding
10th Nov 20207:00 amRNSHalf-year results
15th Oct 202010:20 amPRNHolding(s) in Company
14th Oct 20201:29 pmPRNDirector/PDMR Shareholding
8th Oct 20204:04 pmPRNTotal Voting Rights
24th Sep 202010:33 amPRNDirector/PDMR Shareholding
14th Sep 202012:52 pmPRNHolding(s) in Company
10th Sep 20204:31 pmPRNDirector/PDMR Shareholding
8th Sep 20202:58 pmPRNTotal Voting Rights
8th Sep 20202:48 pmPRNResult of AGM
8th Sep 20207:00 amRNSChairman’s AGM Statement 2020
7th Sep 202012:27 pmPRNHolding(s) in Company
27th Aug 20204:41 pmRNSSecond Price Monitoring Extn
27th Aug 20204:35 pmRNSPrice Monitoring Extension
26th Aug 202012:02 pmRNSPrice Monitoring Extension
25th Aug 202012:02 pmRNSPrice Monitoring Extension
20th Aug 202012:02 pmRNSPrice Monitoring Extension
19th Aug 202012:02 pmRNSPrice Monitoring Extension
18th Aug 202012:03 pmRNSPrice Monitoring Extension
11th Aug 202010:05 amPRNAdditional Listing
11th Aug 20209:51 amPRNDirector/PDMR Shareholding
7th Aug 202012:07 pmRNSSecond Price Monitoring Extn
7th Aug 202012:02 pmRNSPrice Monitoring Extension
6th Aug 202012:07 pmRNSSecond Price Monitoring Extn
6th Aug 202012:02 pmRNSPrice Monitoring Extension
3rd Aug 202012:07 pmRNSSecond Price Monitoring Extn
3rd Aug 202012:02 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.